Coronavirus Vaccines (COVID-19; SARS-COV-2): preliminary review of articles, patents, clinical trials and marke

Detalhes bibliográficos
Autor(a) principal: Quintella, Cristina M.
Data de Publicação: 2020
Outros Autores: Mata, Ana Maria Tavares da, Ghesti, Grace Ferreira, Mata, Pedro Miguel de Assis Lopes Tavares da
Tipo de documento: Artigo
Idioma: por
Título da fonte: Cadernos de Prospecção (Online)
Texto Completo: https://periodicos.ufba.br/index.php/nit/article/view/35871
Resumo: The recent Coronavirus outbreak has sparked a worldwide pandemic. This article consists of an exploratory study to assess the existing volume of material and the potential for further technological assessment and forecast. It is used to assess the knowledge that exists in science (through articles), in technology (through patents), in clinical tests and ready for use (through vaccines available on the market). The articles were mapped on the Web of Knowledge, the patent assessment used the European Worldwide database, using the Orbit® software. 991 patents, 125 articles and 115 clinical studies were found, with only 2 explicitly referring to vaccines. The annual evolution shows an exponential growth from 2002-2004 for articles and for patents. The vast majority of clinical studies have not yet started (only 15% have been completed), showing that there is an urgent need to stimulate their maturation. There is still no vaccine on the market that is considered worldwide effective.
id UFBA-6_874971c31152c04a298aca5e550f9068
oai_identifier_str oai:ojs.periodicos.ufba.br:article/35871
network_acronym_str UFBA-6
network_name_str Cadernos de Prospecção (Online)
repository_id_str
spelling Coronavirus Vaccines (COVID-19; SARS-COV-2): preliminary review of articles, patents, clinical trials and markeVacinas para Coronavírus (COVID-19; SARS-COV-2): mapeamento preliminar de artigos, patentes, testes clínicos e mercadoPandemiaImunizaçãoMicro-organismos BiotecnologiaAvaliação TecnológicaConhecimento CientíficoCOVID-19VacinaCoronavírus.PandemicImmunizationMicroorganismsTechnological EvaluationBiotechnologyScientific KnowledgeCOVID-19VaccineCorona Virus.The recent Coronavirus outbreak has sparked a worldwide pandemic. This article consists of an exploratory study to assess the existing volume of material and the potential for further technological assessment and forecast. It is used to assess the knowledge that exists in science (through articles), in technology (through patents), in clinical tests and ready for use (through vaccines available on the market). The articles were mapped on the Web of Knowledge, the patent assessment used the European Worldwide database, using the Orbit® software. 991 patents, 125 articles and 115 clinical studies were found, with only 2 explicitly referring to vaccines. The annual evolution shows an exponential growth from 2002-2004 for articles and for patents. The vast majority of clinical studies have not yet started (only 15% have been completed), showing that there is an urgent need to stimulate their maturation. There is still no vaccine on the market that is considered worldwide effective.O recente surto de Coronavírus gerou uma pandemia mundial. Este artigo consiste em um estudo exploratório para avaliar parcialmente o volume existente de material e o potencial de aprofundar futuras prospecções tecnológicas. O propósito deste estudo é o de pré-avaliar o conhecimento que existe em ciência (por meio de artigos), em tecnologia (por meio de patentes) e em testes clínicos e prontos para uso (por meio de vacinas disponíveis no mercado). Os artigos foram mapeados na Web of Knowledge, o mapeamento patentário usou a base Worldwide europeia, usando o software Orbit®. Os estudos clínicos utilizaram a base de dados dos Estados Unidos da América (EUA). Foram encontradas 991 patentes, 125 artigos e 115 estudos clínicos sendo apenas dois que se referem explicitamente a vacinas. A evolução anual mostra um crescimento exponencial a partir de 2002-2004 para artigos e para patentes. A grande maioria dos estudos clínicos nem foi ainda iniciada (apenas 15% foram completados), evidenciando que há necessidade urgente de estimular sua maturação. Não existe, no momento, no mercado, uma vacina que seja considerada efetiva mundialmente.Universidade Federal da Bahia2020-03-27info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://periodicos.ufba.br/index.php/nit/article/view/3587110.9771/cp.v13i1.35871Cadernos de Prospecção; Vol. 13 No. 1 (2020); 3Cadernos de Prospecção; v. 13 n. 1 (2020); 32317-00261983-1358reponame:Cadernos de Prospecção (Online)instname:Universidade Federal da Bahia (UFBA)instacron:UFBAporhttps://periodicos.ufba.br/index.php/nit/article/view/35871/20780Copyright (c) 2020 Cadernos de Prospecçãohttps://creativecommons.org/licenses/by-nc/4.0info:eu-repo/semantics/openAccessQuintella, Cristina M. Mata, Ana Maria Tavares daGhesti, Grace FerreiraMata, Pedro Miguel de Assis Lopes Tavares da2020-03-27T18:56:35Zoai:ojs.periodicos.ufba.br:article/35871Revistahttps://periodicos.ufba.br/index.php/nitPUBhttps://periodicos.ufba.br/index.php/nit/oaicadernosdeprospeccao@gmail.com || maliceribeiro@yahoo.com.br || cadernosdeprospeccao@gmail.com || saionaraluna@gmail.com2317-00261983-1358opendoar:2020-03-27T18:56:35Cadernos de Prospecção (Online) - Universidade Federal da Bahia (UFBA)false
dc.title.none.fl_str_mv Coronavirus Vaccines (COVID-19; SARS-COV-2): preliminary review of articles, patents, clinical trials and marke
Vacinas para Coronavírus (COVID-19; SARS-COV-2): mapeamento preliminar de artigos, patentes, testes clínicos e mercado
title Coronavirus Vaccines (COVID-19; SARS-COV-2): preliminary review of articles, patents, clinical trials and marke
spellingShingle Coronavirus Vaccines (COVID-19; SARS-COV-2): preliminary review of articles, patents, clinical trials and marke
Quintella, Cristina M.
Pandemia
Imunização
Micro-organismos
Biotecnologia
Avaliação Tecnológica
Conhecimento Científico
COVID-19
Vacina
Coronavírus.
Pandemic
Immunization
Microorganisms
Technological Evaluation
Biotechnology
Scientific Knowledge
COVID-19
Vaccine
Corona Virus.
title_short Coronavirus Vaccines (COVID-19; SARS-COV-2): preliminary review of articles, patents, clinical trials and marke
title_full Coronavirus Vaccines (COVID-19; SARS-COV-2): preliminary review of articles, patents, clinical trials and marke
title_fullStr Coronavirus Vaccines (COVID-19; SARS-COV-2): preliminary review of articles, patents, clinical trials and marke
title_full_unstemmed Coronavirus Vaccines (COVID-19; SARS-COV-2): preliminary review of articles, patents, clinical trials and marke
title_sort Coronavirus Vaccines (COVID-19; SARS-COV-2): preliminary review of articles, patents, clinical trials and marke
author Quintella, Cristina M.
author_facet Quintella, Cristina M.
Mata, Ana Maria Tavares da
Ghesti, Grace Ferreira
Mata, Pedro Miguel de Assis Lopes Tavares da
author_role author
author2 Mata, Ana Maria Tavares da
Ghesti, Grace Ferreira
Mata, Pedro Miguel de Assis Lopes Tavares da
author2_role author
author
author
dc.contributor.author.fl_str_mv Quintella, Cristina M.
Mata, Ana Maria Tavares da
Ghesti, Grace Ferreira
Mata, Pedro Miguel de Assis Lopes Tavares da
dc.subject.por.fl_str_mv Pandemia
Imunização
Micro-organismos
Biotecnologia
Avaliação Tecnológica
Conhecimento Científico
COVID-19
Vacina
Coronavírus.
Pandemic
Immunization
Microorganisms
Technological Evaluation
Biotechnology
Scientific Knowledge
COVID-19
Vaccine
Corona Virus.
topic Pandemia
Imunização
Micro-organismos
Biotecnologia
Avaliação Tecnológica
Conhecimento Científico
COVID-19
Vacina
Coronavírus.
Pandemic
Immunization
Microorganisms
Technological Evaluation
Biotechnology
Scientific Knowledge
COVID-19
Vaccine
Corona Virus.
description The recent Coronavirus outbreak has sparked a worldwide pandemic. This article consists of an exploratory study to assess the existing volume of material and the potential for further technological assessment and forecast. It is used to assess the knowledge that exists in science (through articles), in technology (through patents), in clinical tests and ready for use (through vaccines available on the market). The articles were mapped on the Web of Knowledge, the patent assessment used the European Worldwide database, using the Orbit® software. 991 patents, 125 articles and 115 clinical studies were found, with only 2 explicitly referring to vaccines. The annual evolution shows an exponential growth from 2002-2004 for articles and for patents. The vast majority of clinical studies have not yet started (only 15% have been completed), showing that there is an urgent need to stimulate their maturation. There is still no vaccine on the market that is considered worldwide effective.
publishDate 2020
dc.date.none.fl_str_mv 2020-03-27
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://periodicos.ufba.br/index.php/nit/article/view/35871
10.9771/cp.v13i1.35871
url https://periodicos.ufba.br/index.php/nit/article/view/35871
identifier_str_mv 10.9771/cp.v13i1.35871
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://periodicos.ufba.br/index.php/nit/article/view/35871/20780
dc.rights.driver.fl_str_mv Copyright (c) 2020 Cadernos de Prospecção
https://creativecommons.org/licenses/by-nc/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2020 Cadernos de Prospecção
https://creativecommons.org/licenses/by-nc/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal da Bahia
publisher.none.fl_str_mv Universidade Federal da Bahia
dc.source.none.fl_str_mv Cadernos de Prospecção; Vol. 13 No. 1 (2020); 3
Cadernos de Prospecção; v. 13 n. 1 (2020); 3
2317-0026
1983-1358
reponame:Cadernos de Prospecção (Online)
instname:Universidade Federal da Bahia (UFBA)
instacron:UFBA
instname_str Universidade Federal da Bahia (UFBA)
instacron_str UFBA
institution UFBA
reponame_str Cadernos de Prospecção (Online)
collection Cadernos de Prospecção (Online)
repository.name.fl_str_mv Cadernos de Prospecção (Online) - Universidade Federal da Bahia (UFBA)
repository.mail.fl_str_mv cadernosdeprospeccao@gmail.com || maliceribeiro@yahoo.com.br || cadernosdeprospeccao@gmail.com || saionaraluna@gmail.com
_version_ 1799319847786512384

Registros relacionados